Two Sigma Advisers’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,703
| Closed | -$124K | – | 2546 |
|
|
2023
Q2 | $124K | Sell |
3,703
-10,984
| -75% | -$369K | ﹤0.01% | 2185 |
|
|
2023
Q1 | $612K | Sell |
14,687
-5,406
| -27% | -$225K | ﹤0.01% | 1861 |
|
|
2022
Q4 | $681K | Sell |
20,093
-9,470
| -32% | -$321K | ﹤0.01% | 1751 |
|
|
2022
Q3 | $1.46M | Buy |
29,563
+5,156
| +21% | +$254K | ﹤0.01% | 1338 |
|
|
2022
Q2 | $959K | Sell |
24,407
-22,393
| -48% | -$880K | ﹤0.01% | 1618 |
|
|
2022
Q1 | $1.73M | Sell |
46,800
-4,440
| -9% | -$164K | ﹤0.01% | 1347 |
|
|
2021
Q4 | $5.01M | Buy |
51,240
+770
| +2% | +$75.3K | 0.01% | 763 |
|
|
2021
Q3 | $6.3M | Sell |
50,470
-4,597
| -8% | -$574K | 0.02% | 687 |
|
|
2021
Q2 | $6.91M | Sell |
55,067
-4,596
| -8% | -$576K | 0.02% | 713 |
|
|
2021
Q1 | $8.1M | Buy |
59,663
+4,660
| +8% | +$633K | 0.02% | 654 |
|
|
2020
Q4 | $5M | Buy |
55,003
+24,246
| +79% | +$2.2M | 0.01% | 816 |
|
|
2020
Q3 | $2.29M | Buy |
30,757
+20,500
| +200% | +$1.52M | 0.01% | 1090 |
|
|
2020
Q2 | $874K | Buy |
10,257
+6,694
| +188% | +$570K | ﹤0.01% | 1640 |
|
|
2020
Q1 | $258K | Buy |
3,563
+1,080
| +43% | +$78.2K | ﹤0.01% | 2076 |
|
|
2019
Q4 | $177K | Sell |
2,483
-57
| -2% | -$4.06K | ﹤0.01% | 2207 |
|
|
2019
Q3 | $133K | Sell |
2,540
-310
| -11% | -$16.2K | ﹤0.01% | 2091 |
|
|
2019
Q2 | $153K | Sell |
2,850
-860
| -23% | -$46.2K | ﹤0.01% | 2169 |
|
|
2019
Q1 | $264K | Buy |
3,710
+1,880
| +103% | +$134K | ﹤0.01% | 2031 |
|
|
2018
Q4 | $146K | Buy |
1,830
+283
| +18% | +$22.6K | ﹤0.01% | 2182 |
|
|
2018
Q3 | $722K | Buy |
1,547
+464
| +43% | +$217K | ﹤0.01% | 1641 |
|
|
2018
Q2 | $431K | Buy |
1,083
+330
| +44% | +$131K | ﹤0.01% | 1974 |
|
|
2018
Q1 | $230K | Buy |
753
+266
| +55% | +$81.2K | ﹤0.01% | 2103 |
|
|
2017
Q4 | $143K | Buy |
+487
| New | +$143K | ﹤0.01% | 2122 |
|